EMCURE PHARMACEUTICALS L
NSE: EMCURE · Healthcare
₹1,846.90
-6.70 (-0.36%)
Last close · 30 Aug 2026, 2:51 am IST
- Open
- ₹1,871.90
- Day high
- ₹1,874.90
- Day low
- ₹1,830.10
- Volume
- 77.3 K
- Prev close
- ₹1,853.60
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 250
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 35,679 Cr
- Price
- 1,881.00
- P/E (TTM)
- 38.61
- P/E (Fwd)
- 24.91
- P/B
- 7.20
- EV/EBITDA
- 20.72
- EV/Revenue
- 4.03
- PEG
- —
- Div Yield
- 0.16%
- 52W High
- 1,944.00
- 52W Low
- 1,260.00
- Beta
- -0.02
Profitability & income
- Revenue (TTM)
- 9,204 Cr
- Net Income (TTM)
- 924 Cr
- EBITDA
- 1,789 Cr
- Gross Margin
- 60.27%
- Op. Margin
- 15.35%
- Net Margin
- 10.04%
- ROE
- 19.57%
- ROA
- 9.62%
- EPS (TTM)
- 48.72
- EPS (Fwd)
- 75.52
Financial health
- Total Debt
- 1,521 Cr
- Total Cash
- 148 Cr
- Debt/Equity
- 30.57
- Current Ratio
- 1.43
- Quick Ratio
- 0.71
- Book Value
- 261.12
- Free Cash Flow
- 311 Cr
- Op. Cash Flow
- 944 Cr
Growth
- Revenue Growth
- 16.70%
- Earnings Growth
- 28.80%
- Earnings QoQ
- 28.80%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,470 Cr | 243 Cr | 494 Cr | 379 Cr | 1,467 Cr | — | 1,521 Cr | 4,950 Cr |
| 2025-12-31 | 2,363 Cr | 231 Cr | 456 Cr | 355 Cr | 1,401 Cr | — | — | — |
| 2025-09-30 | 2,270 Cr | 243 Cr | 479 Cr | 334 Cr | 1,380 Cr | — | 1,659 Cr | 4,743 Cr |
| 2025-06-30 | 2,101 Cr | 207 Cr | 417 Cr | 304 Cr | 1,299 Cr | — | — | — |
| 2025-03-31 | 2,116 Cr | 189 Cr | 396 Cr | 293 Cr | 1,224 Cr | — | 1,023 Cr | 4,446 Cr |
| 2024-12-31 | — | — | — | — | — | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 9,204 Cr | 924 Cr | 1,846 Cr | 1,374 Cr | 5,546 Cr | 944 Cr | 1,521 Cr | 4,950 Cr |
| 2025-03-31 | 7,896 Cr | 681 Cr | 1,531 Cr | 1,085 Cr | 4,749 Cr | 852 Cr | 1,023 Cr | 4,446 Cr |
| 2024-03-31 | 6,582 Cr | 498 Cr | 1,240 Cr | 917 Cr | 3,972 Cr | 1,097 Cr | 2,335 Cr | 2,952 Cr |
| 2023-03-31 | 5,931 Cr | 532 Cr | 1,170 Cr | 941 Cr | 3,523 Cr | 747 Cr | 2,334 Cr | 2,501 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for EMCURE?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in